Global Transthyretin Market Insights, Forecast to 2025

2018-12-05 / 3900.00 / Pharma & Healthcare / 116 Pages

Description

In 2017, the global Transthyretin market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Transthyretin market based on company, product type, application and key regions.

This report studies the global market size of Transthyretin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transthyretin in these regions.
This research report categorizes the global Transthyretin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Transthyretin include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Transthyretin include
Alnylam Pharmaceuticals Inc
Arcturus Therapeutics Inc
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
Pfizer Inc
Prothena Corp Plc
Regeneron Pharmaceuticals Inc

Market Size Split by Type
AG-10
ALN-TTRsc02
CRX-1008
EDE-1307
Inotersen Sodium
Others
Market Size Split by Application
Familial Amyloid Neuropathies
Alzheimer's Disease
Cardomyopathy
Neuropathy
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Transthyretin market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Transthyretin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Transthyretin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transthyretin with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Transthyretin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Transthyretin are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transthyretin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Study Coverage
1.1 Transthyretin Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Transthyretin Market Size Growth Rate by Type
1.4.2 AG-10
1.4.3 ALN-TTRsc02
1.4.4 CRX-1008
1.4.5 EDE-1307
1.4.6 Inotersen Sodium
1.4.7 Others
1.5 Market by Application
1.5.1 Global Transthyretin Market Size Growth Rate by Application
1.5.2 Familial Amyloid Neuropathies
1.5.3 Alzheimer's Disease
1.5.4 Cardomyopathy
1.5.5 Neuropathy
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Transthyretin Market Size
2.1.1 Global Transthyretin Revenue 2016-2025
2.1.2 Global Transthyretin Sales 2016-2025
2.2 Transthyretin Growth Rate by Regions
2.2.1 Global Transthyretin Sales by Regions
2.2.2 Global Transthyretin Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Transthyretin Sales by Manufacturers
3.1.1 Transthyretin Sales by Manufacturers
3.1.2 Transthyretin Sales Market Share by Manufacturers
3.1.3 Global Transthyretin Market Concentration Ratio (CR5 and HHI)
3.2 Transthyretin Revenue by Manufacturers
3.2.1 Transthyretin Revenue by Manufacturers (2016-2018)
3.2.2 Transthyretin Revenue Share by Manufacturers (2016-2018)
3.3 Transthyretin Price by Manufacturers
3.4 Transthyretin Manufacturing Base Distribution, Product Types
3.4.1 Transthyretin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transthyretin Product Category
3.4.3 Date of International Manufacturers Enter into Transthyretin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Transthyretin Sales by Type
4.2 Global Transthyretin Revenue by Type
4.3 Transthyretin Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Transthyretin Breakdown Data by Application

6 North America
6.1 North America Transthyretin by Countries
6.1.1 North America Transthyretin Sales by Countries
6.1.2 North America Transthyretin Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Transthyretin by Type
6.3 North America Transthyretin by Application
6.4 North America Transthyretin by Company

7 Europe
7.1 Europe Transthyretin by Countries
7.1.1 Europe Transthyretin Sales by Countries
7.1.2 Europe Transthyretin Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transthyretin by Type
7.3 Europe Transthyretin by Application
7.4 Europe Transthyretin by Company

8 Asia Pacific
8.1 Asia Pacific Transthyretin by Countries
8.1.1 Asia Pacific Transthyretin Sales by Countries
8.1.2 Asia Pacific Transthyretin Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Transthyretin by Type
8.3 Asia Pacific Transthyretin by Application
8.4 Asia Pacific Transthyretin by Company

9 Central & South America
9.1 Central & South America Transthyretin by Countries
9.1.1 Central & South America Transthyretin Sales by Countries
9.1.2 Central & South America Transthyretin Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Transthyretin by Type
9.3 Central & South America Transthyretin by Application
9.4 Central & South America Transthyretin by Company

10 Middle East and Africa
10.1 Middle East and Africa Transthyretin by Countries
10.1.1 Middle East and Africa Transthyretin Sales by Countries
10.1.2 Middle East and Africa Transthyretin Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Transthyretin by Type
10.3 Middle East and Africa Transthyretin by Application
10.4 Middle East and Africa Transthyretin by Company

11 Company Profiles
11.1 Alnylam Pharmaceuticals Inc
11.1.1 Alnylam Pharmaceuticals Inc Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Transthyretin
11.1.4 Transthyretin Product Description
11.1.5 Recent Development
11.2 Arcturus Therapeutics Inc
11.2.1 Arcturus Therapeutics Inc Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Transthyretin
11.2.4 Transthyretin Product Description
11.2.5 Recent Development
11.3 Ionis Pharmaceuticals Inc
11.3.1 Ionis Pharmaceuticals Inc Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Transthyretin
11.3.4 Transthyretin Product Description
11.3.5 Recent Development
11.4 Neurimmune Holding AG
11.4.1 Neurimmune Holding AG Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Transthyretin
11.4.4 Transthyretin Product Description
11.4.5 Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Transthyretin
11.5.4 Transthyretin Product Description
11.5.5 Recent Development
11.6 Prothena Corp Plc
11.6.1 Prothena Corp Plc Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Transthyretin
11.6.4 Transthyretin Product Description
11.6.5 Recent Development
11.7 Regeneron Pharmaceuticals Inc
11.7.1 Regeneron Pharmaceuticals Inc Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Transthyretin
11.7.4 Transthyretin Product Description
11.7.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Transthyretin Raw Material
13.1.2 Transthyretin Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Picture of Transthyretin
Figure Global Transthyretin Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Transthyretin Production Market Share by Types (Product Category) in 2017
Figure AG-10 Product Picture
Table Major Manufacturers of AG-10
Figure ALN-TTRsc02 Product Picture
Table Major Manufacturers of ALN-TTRsc02
Figure CRX-1008 Product Picture
Table Major Manufacturers of CRX-1008
Figure EDE-1307 Product Picture
Table Major Manufacturers of EDE-1307
Figure Inotersen Sodium Product Picture
Table Major Manufacturers of Inotersen Sodium
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Transthyretin Market Size Growth Rate by Application 2018-2025 (K Pcs)
Figure Familial Amyloid Neuropathies
Figure Alzheimer's Disease
Figure Cardomyopathy
Figure Neuropathy
Figure Others
Figure Transthyretin Report Years Considered
Figure Global Transthyretin Market Size 2016-2025 (Million US$)
Figure Global Transthyretin Sales 2016-2025 (K Pcs)
Table Global Transthyretin Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
Table Global Transthyretin Sales by Regions 2016-2025 (K Pcs)
Table Global Transthyretin Sales Market Share by Regions 2016-2025
Figure Global Transthyretin Sales Market Share by Regions 2016-2025
Figure 2017 Global Transthyretin Sales Market Share by Regions
Table Global Transthyretin Revenue by Regions 2016-2025 (Million US$)
Table Global Transthyretin Revenue Market Share by Regions 2016-2025
Figure Global Transthyretin Revenue Market Share by Regions 2016-2025
Figure 2017 Global Transthyretin Revenue Market Share by Regions
Table Global Transthyretin Sales by Manufacturers (2016-2018) (K Pcs)
Table Global Transthyretin Sales Share by Manufacturers (2016-2018)
Figure Global Transthyretin Sales Share by Manufacturers in 2017
Table Transthyretin Revenue by Manufacturers (2016-2018) (Million US$)
Table Transthyretin Revenue Share by Manufacturers (2016-2018)
Figure Transthyretin Value Share by Manufacturers in 2017
Table Global Transthyretin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Transthyretin Price (2016-2018) (USD/Pcs)
Table Transthyretin Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Transthyretin Product Category
Table Date of International Manufacturers Enter into Transthyretin Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Transthyretin Sales by Type (2016-2025) (K Pcs)
Table Global Transthyretin Sales Share by Type (2016-2025)
Figure Global Transthyretin Sales Market Share by Type (2016-2025)
Figure Global Transthyretin Sales Market Share by Type in 2017
Table Global Transthyretin Revenue by Type (2016-2025) (Million US$)
Table Global Transthyretin Revenue Share by Type (2016-2025)
Figure Global Transthyretin Revenue Market Share by Type (2016-2025)
Figure Global Transthyretin Revenue Market Share by Type in 2017
Table Transthyretin Price by Type 2013-2018 (USD/Pcs)
Table Global Transthyretin Sales by Application (2016-2025) (K Pcs)
Table Global Transthyretin Sales Share by Application (2016-2025)
Figure Global Sales Transthyretin Market Share by Application (2016-2025)
Figure Global Sales Transthyretin Market Share by Application (2016-2025)
Figure North America Transthyretin Sales Growth Rate 2016-2025 (K Pcs)
Figure North America Transthyretin Revenue Growth Rate 2016-2025 (Million US$)
Table North America Transthyretin Sales by Countries (2016-2025) (K Pcs)
Table North America Transthyretin Sales Market Share by Countries (2016-2025)
Figure 2017 North America Transthyretin Sales Market Share by Countries
Table North America Transthyretin Revenue by Countries (2016-2025) (Million US$)
Table North America Transthyretin Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Transthyretin Revenue Market Share by Countries
Figure United States Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure United States Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Canada Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Mexico Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Table North America Transthyretin Sales by Type (2016-2025) (K Pcs)
Table North America Transthyretin Sales Market Share by Type (2016-2025)
Figure 2017 North America Transthyretin Market Share by Type
Table North America Transthyretin Sales by Application (2016-2025) (K Pcs)
Table North America Transthyretin Sales Market Share by Application (2016-2025)
Figure 2017 North America Transthyretin Market Share by Application
Table North America Transthyretin Sales by Company (2016-2018) (K Pcs)
Table North America Transthyretin Sales Market Share by Company (2016-2018)
Figure North America Transthyretin Sales Market Share by Company in 2017
Figure Europe Transthyretin Sales Growth Rate 2016-2025 (K Pcs)
Figure Europe Transthyretin Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Transthyretin Sales by Countries (2016-2025) (K Pcs)
Table Europe Transthyretin Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Transthyretin Sales Market Share by Countries
Table Europe Transthyretin Revenue by Countries (2016-2025) (Million US$)
Table Europe Transthyretin Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Transthyretin Revenue Market Share by Countries
Figure Germany Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Germany Transthyretin Revenue Growth Rate (2016-2025) (K Pcs)
Figure France Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure France Transthyretin Revenue Growth Rate (2016-2025) (K Pcs)
Figure UK Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure UK Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Italy Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Russia Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Transthyretin Sales by Type (2016-2025) (K Pcs)
Table Europe Transthyretin Sales Market Share by Type (2016-2025)
Figure 2017 Europe Transthyretin Market Share by Type
Table Europe Transthyretin Sales by Application (2016-2025) (K Pcs)
Table Europe Transthyretin Sales Market Share by Application (2016-2025)
Figure 2017 Europe Transthyretin Market Share by Application
Table Europe Transthyretin Sales by Company (2016-2018) (K Pcs)
Table Europe Transthyretin Sales Market Share by Company (2016-2018)
Figure Europe Transthyretin Sales Market Share by Company in 2017
Figure Asia Pacific Transthyretin Sales Growth Rate 2016-2025 (K Pcs)
Figure Asia Pacific Transthyretin Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Transthyretin Sales by Countries (2016-2025) (K Pcs)
Table Asia Pacific Transthyretin Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Transthyretin Sales Market Share by Countries
Table Asia Pacific Transthyretin Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Transthyretin Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Transthyretin Revenue Market Share by Countries
Figure China Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure China Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Japan Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Korea Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure India Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure India Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Australia Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Indonesia Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Malaysia Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Philippines Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Thailand Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Vietnam Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Singapore Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Transthyretin Sales by Type (2016-2025) (K Pcs)
Table Asia Pacific Transthyretin Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Transthyretin Market Share by Type
Table Asia Pacific Transthyretin Sales by Application (2016-2025) (K Pcs)
Table Asia Pacific Transthyretin Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Transthyretin Market Share by Application
Table Asia Pacific Transthyretin Sales by Company (2016-2018) (K Pcs)
Table Asia Pacific Transthyretin Sales Market Share by Company (2016-2018)
Figure Asia Pacific Transthyretin Sales Market Share by Company in 2017
Figure Central & South America Transthyretin Sales Growth Rate 2016-2025 (K Pcs)
Figure Central & South America Transthyretin Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Transthyretin Sales by Countries (2016-2025) (K Pcs)
Table Central & South America Transthyretin Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Transthyretin Sales Market Share by Countries
Table Central & South America Transthyretin Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Transthyretin Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Transthyretin Revenue Market Share by Countries
Figure Brazil Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Brazil Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Argentina Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Transthyretin Sales by Type (2016-2025) (K Pcs)
Table Central & South America Transthyretin Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Transthyretin Market Share by Type
Table Central & South America Transthyretin Sales by Application (2016-2025) (K Pcs)
Table Central & South America Transthyretin Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Transthyretin Market Share by Application
Table Central & South America Transthyretin Sales by Company (2016-2018) (K Pcs)
Table Central & South America Transthyretin Sales Market Share by Company (2016-2018)
Figure Central & South America Transthyretin Sales Market Share by Company in 2017
Figure Middle East and Africa Transthyretin Sales Growth Rate 2016-2025 (K Pcs)
Figure Middle East and Africa Transthyretin Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Transthyretin Sales by Countries (2016-2025) (K Pcs)
Table Middle East and Africa Transthyretin Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Transthyretin Sales Market Share by Countries
Table Middle East and Africa Transthyretin Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Transthyretin Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Transthyretin Revenue Market Share by Countries
Figure GCC Countries Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure GCC Countries Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Turkey Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure Egypt Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Transthyretin Sales Growth Rate (2016-2025) (K Pcs)
Figure South Africa Transthyretin Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Transthyretin Sales by Type (2016-2025) (K Pcs)
Table Middle East and Africa Transthyretin Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Transthyretin Market Share by Type
Table Middle East and Africa Transthyretin Sales by Application (2016-2025) (K Pcs)
Table Middle East and Africa Transthyretin Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Transthyretin Market Share by Application
Table Middle East and Africa Transthyretin Sales by Company (2016-2018) (K Pcs)
Table Middle East and Africa Transthyretin Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Transthyretin Sales Market Share by Company in 2017
Table Alnylam Pharmaceuticals Inc Company Details
Table Alnylam Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Alnylam Pharmaceuticals Inc Recent Development
Table Arcturus Therapeutics Inc Company Details
Table Arcturus Therapeutics Inc Transthyretin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Arcturus Therapeutics Inc Recent Development
Table Ionis Pharmaceuticals Inc Company Details
Table Ionis Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Ionis Pharmaceuticals Inc Recent Development
Table Neurimmune Holding AG Company Details
Table Neurimmune Holding AG Transthyretin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Neurimmune Holding AG Recent Development
Table Pfizer Inc Company Details
Table Pfizer Inc Transthyretin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Pfizer Inc Recent Development
Table Prothena Corp Plc Company Details
Table Prothena Corp Plc Transthyretin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Prothena Corp Plc Recent Development
Table Regeneron Pharmaceuticals Inc Company Details
Table Regeneron Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Regeneron Pharmaceuticals Inc Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Transthyretin Value Chain
Table Typical Suppliers of Key Transthyretin Raw Material
Table Transthyretin Customers List
Table Transthyretin Sales Channels
Table Transthyretin Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory